KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agenus (AGEN) Research & Development (2016 - 2025)

Agenus has reported Research & Development over the past 16 years, most recently at $7.5 million for Q4 2025.

  • Quarterly results put Research & Development at $7.5 million for Q4 2025, down 77.76% from a year ago — trailing twelve months through Dec 2025 was $79.3 million (down 48.99% YoY), and the annual figure for FY2025 was $79.3 million, down 48.99%.
  • Research & Development for Q4 2025 was $7.5 million at Agenus, down from $23.6 million in the prior quarter.
  • Over the last five years, Research & Development for AGEN hit a ceiling of $66.7 million in Q4 2023 and a floor of $7.5 million in Q4 2025.
  • Median Research & Development over the past 5 years was $43.4 million (2021), compared with a mean of $41.7 million.
  • Biggest five-year swings in Research & Development: skyrocketed 50.37% in 2021 and later tumbled 77.76% in 2025.
  • Agenus' Research & Development stood at $53.5 million in 2021, then dropped by 0.39% to $53.3 million in 2022, then increased by 25.23% to $66.7 million in 2023, then tumbled by 49.38% to $33.8 million in 2024, then plummeted by 77.76% to $7.5 million in 2025.
  • The last three reported values for Research & Development were $7.5 million (Q4 2025), $23.6 million (Q3 2025), and $26.7 million (Q2 2025) per Business Quant data.